Results 201 to 210 of about 112,411 (265)

Visualization of childhood allergic diseases based on VOSviewer and CiteSpace. [PDF]

open access: yesFront Med (Lausanne)
Wang Y   +8 more
europepmc   +1 more source

Investigation into the delivery and evaluation of a unique Avena sativa (Oat) Lipid Extract on skin barrier using LC‒MS/MS, Raman spectroscopy, immunostaining analysis and skin efficacy

open access: yesInternational Journal of Cosmetic Science, EarlyView.
Abstract Objectives Oat lipids are rich in ceramides. In this investigation, we analysed the delivery of a specific Oat Lipid Extract derived from Avena sativa, comprising ‘skin identical’ ratios of fatty acids, ceramides and cholesterol/sterol. This investigation is the first reported investigation of oat lipids utilizing Raman spectroscopy for the ...
E. Gombert, C. Dewis
wiley   +1 more source

Development of the SkinCARE Questionnaire: Measuring the impact of skin issues on psychological wellbeing in healthy populations

open access: yesInternational Journal of Cosmetic Science, EarlyView.
The SkinCARE questionnaire is a validated tool for assessing the impact of skin condition on psychological wellbeing. The present data also suggest greater skin wellbeing is linked to lower levels of perceived stress and good sleep health. Abstract Background In recent years, the psychological dimension of skin health has attracted increasing research ...
Alice Newton‐Fenner   +7 more
wiley   +1 more source

Knowledge, attitudes, and practices of hand eczema patients in Guangdong, China. [PDF]

open access: yesFront Public Health
Zheng J   +6 more
europepmc   +1 more source

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao   +26 more
wiley   +1 more source

Empathy for the Patient with Chronic Hand Eczema. [PDF]

open access: yesDermatol Ther (Heidelb)
Tooks M, Bunick CG.
europepmc   +1 more source

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo   +11 more
wiley   +1 more source

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study. [PDF]

open access: yesFront Immunol
Russo F   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy